The article highlights the key points associated with the regulatory framework for specific categories of medicinal products. Table of content ...

The article provides an overview of the approach to be applied when calculating regulatory fees associated with registration...

The first IL-23p19 targeted biologic recommended by the National Institute for Health and Care Excellence (NICE) for moderately to severely active ulcerative colitis (UC)...

Oberweis, C. V., Marchal, J. A., López-Ruiz, E. & Gálvez-Martín, P. A worldwide overview of regulatory frameworks for tissue-based products. Tissue Eng. B 26,...

The average cannabis consumer tends to use a product's THC percentage as a benchmark for their purchase. But THC isn't the end-all-be-all of what...

The pharmacokinetic properties of a new chemical entity (NCE) or an investigational medicinal product (IMP) must...

The world 3rd largest gene and cell therapy (CGT) cluster, the UK CGT Catapult has expanded its operations opening a subsidiary in Edinburgh....

Introduction The Delhi High Court (“HC”), in recent months, has been called upon to pass an interim injunction order against an alleged trademark...

The Falsified Medicines Directive (2011/62/EU) (FMD) was introduced in 2011 with the aim of safeguarding the public against medicinal products within the EU whose...

The European Court has ruled in joined cases C‑253/20 and C‑254/20 Impexeco NV v Novartis AG which target the issue of pharmaceutical products...

Table of Contents A good way to wind down? A gateway substance? Or so much more? Whether you’re 420-friendly or not, the perception of cannabis...

It’s been another IP heavy week for the Indian IP landscape! Here is the last week’s review, discussing the 5 posts published...